|
Español
English
|
Dadun >
Browsing by Author Gullon, A. (Arturo)
Showing results 1 to 10 of 10
| Issue Date | Title | Author(s) | | 1995 | A recurrent translocation, t(3;11)(q21;q13), found in two distinct cases of acute myeloid leukemia | Cigudosa, J.C. (Juan Cruz); Calasanz, M.J. (Maria José); Odero, M.D. (María D.); Marin, J. (Julián); Bengoechea, E. (E.); Gullon, A. (Arturo) |
| 1995 | A variant t(14;17) in acute promyelocytic leukemia. Positive response to retinoic acid treatment | Cigudosa, J.C. (Juan Cruz); Calasanz, M.J. (Maria José); Odero, M.D. (María D.); Marin, J. (Julián); Bengoechea, E. (E.); Gullon, A. (Arturo) |
| 1994 | CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro | Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Golvano, J.J. (José Javier); Prieto, I. (Isidro); Civeira, M.P. (María Pilar); Gullon, A. (Arturo); Sarin, P.S. (Prem S.); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1997 | Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations | Calasanz, M.J. (Maria José); Cigudosa, J.C. (Juan Cruz); Odero, M.D. (María D.); Ferreira, C. (C.); Ardanaz, M.T. (M.T.); Fraile, A. (A.); Carrasco, J. (J.L.); Sole, F. (Francesc); Cuesta, B. (Braulia); Gullon, A. (Arturo) |
| 1993 | Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells | Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Larrea, E. (Esther); Golvano, J.J. (José Javier); Prieto, I. (Inés); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1996 | Further insights on the inhibition of HIV type 1 infection in vitro by CD4-modified synthetic peptides containing phenylalanine | Prieto, I. (Isidro); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Golvano, J.J. (José Javier); Civeira, M.P. (María Pilar); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1991 | Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide | Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Golvano, J.J. (José Javier); Gullon, A. (Arturo); Civeira, M.P. (María Pilar); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1992 | Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct | Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1994 | Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr | Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Golvano, J.J. (José Javier); Prieto, I. (Isidro); Gullon, A. (Arturo); Soto, M.J. (María José); Labarga, P. (Pablo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1990 | Polarity of immunogens: implications for vaccine design | Golvano, J.J. (José Javier); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
Showing results 1 to 10 of 10
|
